MILFORD, Mass.--(BUSINESS WIRE)-- In April 2010 Avecia announced a manufacturing agreement with Pfizer for the commercial supply of the oligonucleotide component of Macugen®. Now two other clients of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback